Mark Hull
Impact in
- Pharmacology top 0.5%
- Inflammatory mediators and NSAID effects
- Cancer Research top 2%
- Cancer, Lipids, and Metabolism
Papers in
- Pharmacology 34
- Inflammatory mediators and NSAID effects 34
-
- Cancer, Lipids, and Metabolism 17
- Co-authors
- Gillian Hawcroft (14 shared papers)Paul M. Loadman (18 shared papers)Patricia Louise Coletta (16 shared papers)Prashant Kant (7 shared papers)Melvyn Lionel Smith (1 shared paper)Giles J. Toogood (12 shared papers)Venkataraman Subramanian (7 shared papers)Jesper Lagergren (6 shared papers)
- Journals
- Gut (14 papers)Gastroenterology (6 papers)International Journal of Cancer (4 papers)European Journal of Cancer (3 papers)Prostaglandins Leukotrienes and Essential Fatty Acids (3 papers)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Mark Hull
117 papers receiving 4.7k citations
Mark Hull's Hit Papers
Peers
Comparison fields: 5 of 133
- Pharmacology 1.0k
- Cancer Research 764
- Biochemistry 293
- Oncology 1.0k
- Nutrition and Dietetics 474
Countries citing papers authored by Mark Hull
This map shows the geographic impact of Mark Hull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Hull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Hull more than expected).
Fields of papers citing papers by Mark Hull
This network shows the impact of papers produced by Mark Hull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Hull. The network helps show where Mark Hull may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Hull, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 123 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A randomised trial of the effect of omega-3 polyunsaturated fatty acid supplements on the human intestinal microbiota Hit paper breakdown → | 2017 | 421 |
| 2 | 2000 | 240 | |
| 3 | 2011 | 229 | |
| 4 | 2000 | 200 | |
| 5 | 2010 | 196 | |
| 6 | 2004 | 136 | |
| 7 | 2005 | 131 | |
| 8 | 2018 | 125 | |
| 9 | 1999 | 123 | |
| 10 | 2013 | 117 | |
| 11 | 2020 | 104 | |
| 12 | 2013 | 98 | |
| 13 | 2014 | 96 | |
| 14 | 2011 | 93 | |
| 15 | 2018 | 90 | |
| 16 | 2017 | 85 | |
| 17 | 2014 | 84 | |
| 18 | 2018 | 84 | |
| 19 | 2003 | 81 | |
| 20 | 2001 | 81 |
About Mark Hull
Mark Hull is a scholar working on Pharmacology, Cancer Research, Oncology, Nutrition and Dietetics and Genetics, having authored 123 papers that have together received 4.9k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (34 papers), Colorectal Cancer Screening and Detection (22 papers), Cancer, Lipids, and Metabolism (17 papers), Fatty Acid Research and Health (13 papers), Estrogen and related hormone effects (11 papers), Helicobacter pylori-related gastroenterology studies (8 papers), Bariatric Surgery and Outcomes (7 papers) and Genetic factors in colorectal cancer (5 papers). The work is most often cited by research in Pharmacology (1.0k citations), Cancer Research (764 citations), Biochemistry (293 citations), Oncology (1.0k citations) and Nutrition and Dietetics (474 citations). Mark Hull has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Gillian Hawcroft, Paul M. Loadman, Patricia Louise Coletta, Prashant Kant, Melvyn Lionel Smith, Giles J. Toogood, Venkataraman Subramanian, Jesper Lagergren, Andrea Belluzzi and Milène Volpato. Their work appears in journals such as Gut, Gastroenterology, International Journal of Cancer, European Journal of Cancer and Prostaglandins Leukotrienes and Essential Fatty Acids.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.